[go: up one dir, main page]

FI970696A7 - Oligonukleotidikonjugaatit, koostumukset ja menetelmät ribonukleiiniha ppojen hajoittamiseksi - Google Patents

Oligonukleotidikonjugaatit, koostumukset ja menetelmät ribonukleiiniha ppojen hajoittamiseksi Download PDF

Info

Publication number
FI970696A7
FI970696A7 FI970696A FI970696A FI970696A7 FI 970696 A7 FI970696 A7 FI 970696A7 FI 970696 A FI970696 A FI 970696A FI 970696 A FI970696 A FI 970696A FI 970696 A7 FI970696 A7 FI 970696A7
Authority
FI
Finland
Prior art keywords
compositions
methods
ribonucleic acids
oligonucleotide conjugates
degrading
Prior art date
Application number
FI970696A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI970696L (fi
FI970696A0 (fi
Inventor
Dieter Hüsken
Heinz Moser
Robert Häner
Jonathan Hall
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of FI970696L publication Critical patent/FI970696L/fi
Publication of FI970696A0 publication Critical patent/FI970696A0/fi
Publication of FI970696A7 publication Critical patent/FI970696A7/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6816Hybridisation assays characterised by the detection means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0042Photocleavage of drugs in vivo, e.g. cleavage of photolabile linkers in vivo by UV radiation for releasing the pharmacologically-active agent from the administered agent; photothrombosis or photoocclusion
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
FI970696A 1994-09-02 1995-08-30 Oligonukleotidikonjugaatit, koostumukset ja menetelmät ribonukleiiniha ppojen hajoittamiseksi FI970696A7 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH269494 1994-09-02
PCT/EP1995/003408 WO1996007667A1 (de) 1994-09-02 1995-08-30 Oligonukleotidkonjugate, zusammensetzungen und verfahren zur spaltung von ribonukleinsäuren

Publications (3)

Publication Number Publication Date
FI970696L FI970696L (fi) 1997-02-19
FI970696A0 FI970696A0 (fi) 1997-02-19
FI970696A7 true FI970696A7 (fi) 1997-02-19

Family

ID=4239485

Family Applications (1)

Application Number Title Priority Date Filing Date
FI970696A FI970696A7 (fi) 1994-09-02 1995-08-30 Oligonukleotidikonjugaatit, koostumukset ja menetelmät ribonukleiiniha ppojen hajoittamiseksi

Country Status (8)

Country Link
EP (1) EP0778845A1 (de)
JP (1) JPH10505353A (de)
AU (1) AU3519095A (de)
CA (1) CA2197785A1 (de)
FI (1) FI970696A7 (de)
HU (1) HUT77034A (de)
NO (1) NO970885L (de)
WO (1) WO1996007667A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5798491A (en) * 1993-06-09 1998-08-25 Board Of Regents, The University Of Texas System Multi-mechanistic chemical cleavage using certain metal complexes
US5714328A (en) * 1995-06-07 1998-02-03 Board Of Regents, The University Of Texas System RNA photocleavage using texaphyrins
CA2263137A1 (en) * 1996-08-20 1998-02-26 Pharmacyclics, Inc. Nucleic acids internally-derivatized with a texaphyrin metal complex and uses thereof
US6022959A (en) * 1996-08-20 2000-02-08 Pharmacyclics, Inc. Nucleic acids internally-derivatized with a texaphyrin metal complex and uses thereof
US6255476B1 (en) * 1999-02-22 2001-07-03 Pe Corporation (Ny) Methods and compositions for synthesis of labelled oligonucleotides and analogs on solid-supports
KR101040700B1 (ko) * 2006-11-16 2011-06-10 주식회사 엘지화학 테레프탈알데히드의 정제방법
WO2008124614A1 (en) 2007-04-06 2008-10-16 Neurocrine Biosciences, Inc. Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
PE20090044A1 (es) 2007-04-06 2009-01-23 Neurocrine Biosciences Inc Antagonistas del receptor de la hormona liberadora de gonadotropina y procedimientos relacionados con los mismos

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5559207A (en) * 1989-03-06 1996-09-24 Board Of Regents, University Of Texas Texaphyrin metal complex mediated ester hydrolysis

Also Published As

Publication number Publication date
HUT77034A (hu) 1998-03-02
CA2197785A1 (en) 1996-03-14
FI970696L (fi) 1997-02-19
FI970696A0 (fi) 1997-02-19
WO1996007667A1 (de) 1996-03-14
NO970885L (no) 1997-04-25
AU3519095A (en) 1996-03-27
NO970885D0 (no) 1997-02-27
EP0778845A1 (de) 1997-06-18
JPH10505353A (ja) 1998-05-26

Similar Documents

Publication Publication Date Title
FI962799L (fi) Nukleiinihappoja sisältävä valmiste, sen valmistus ja käyttö
FI973363A7 (fi) Nukleiinihappoja sisältävä koostumus, sen valmistus ja käyttö
FI971176L (fi) DNA-fotopilkkominen käyttäen teksapyriinejä
AU2215995A (en) Freeze-dried compositions comprising rna
EE9500064A (et) Asendatud 1H-imidasoolid, nende valmistamismeetodid ja farmatseutilised kompositsioonid
IL133293A0 (en) Pharmaceutical compositions comprising cyclodextrins
NL300150I1 (nl) 4"-Gesubstitueerde 9-deoxo-9A-AZA-9A-homoërythromycine-A-derivaten.
FI963692L (fi) Menetelmiä ja koostumuksia, jotka ovat käyttökelpoisia angiogeneesin inhibointiin
FI963183A0 (fi) Vesipitoinen dispersiokoostumus, ja sitä käyttävä koostumus
DE59811528D1 (de) Hypolipidämische Propanolaminderivate
IL137162A0 (en) 2,3,4,5-tetrahydro -1h- [1,4]-benzodiazepine -3- hydroxamic acids as matrix metalloproteinase inhibitors
FI972264L (fi) Betaiinituote, menetelmä sen valmistamiseksi, ja sen käyttö
FI970740A7 (fi) Funktionaaliset terpyridiini-metallikompleksit, menetelmät niiden valmistamiseksi ja oligonukleotidikonjugaatit terpyridiini-metallikompleksien kanssa
FI953578L (fi) Ksylanaasi, sitä tuottava mikro-organismi, DNA-molekyyli, menetelmä ksylanaasin valmistamiseksi ja sen käyttö
FI970696A7 (fi) Oligonukleotidikonjugaatit, koostumukset ja menetelmät ribonukleiiniha ppojen hajoittamiseksi
FI972988L (fi) Menetelmiä ja farmaseuttisia koostumuksia, joissa käytetään desmetyyliselegiliiniä
EE04398B1 (et) Asendatud 1,2,3,4,5,6-heksahüdro-2,6-metano-3-bensasotsiin-10-oolid, nende valmistamise meetod ja kasutamine ravimitena
FI972186L (fi) Menetelmä isomaltuloosin ja muiden tuotteiden valmistamiseksi
EE03996B1 (et) Farmatseutilised kompositsioonid, nende valmistamismeetod ja kasutamine
FI955399L (fi) Polyolikoostumus, menetelmä sen valmistamiseksi ja sen käytöt
FI982412L (fi) Rehu ja menetelmä sen valmistamiseksi
ZA967817B (en) Phenylacetic acids, their preparation, and compositions comprising them.
FI933507A7 (fi) Bisyklopolyatsamakrosyklofosfonihappoja, niiden komplekseja ja konjuga atteja käytettäväksi varjoaineina ja menetelmä niiden valmistamiseksi
IT246279Y1 (it) Guarnitura per mobili
FI933506A7 (fi) Bisyklopolyatsamakrosyklokarboksyylihappokomplekseja, niiden konjugaat teja, menetelmä niiden valmistamiseksi ja käyttö varjoaineina